However, increased H3K9me2 levels have been observed in the prefrontal cortex of AD patients, particularly at the promoter region of neprilysin (NEP) gene, which encodes a protein responsible for of Aβ peptide degradation. The gene discussed is MME; the disease is Alzheimer disease.